Related Funds
Fund Name | Location |
Alpenroute Asset Management | Seoul, Seoul-t'ukpyolsi, South Korea |
Biomatics Capital Partners | Seattle, United States, Washington |
Blockhead Capital | California, Santa Monica, United States |
Clover Health | Nashville, Tennessee, United States |
DFJ Portage Ventures | Minnesota, Northfield, United States |
Guava Capital | - |
Hongxinyuan | China, Qingdao, Shandong |
Intelcan Technosystems | Canada, Ontario, Ottawa |
Iscal Holdings | Israel, Tel Aviv, Tel Aviv District |
Jianxin Capital | China, Shanghai |
Martlet | Cambridge, Cambridgeshire, United Kingdom |
Rabo Corporate Investments | The Netherlands, Utrecht, Utrecht |
Sanxie Jinshi Investment Management | China, Guangdong, Shenzhen |
SAR GROUP | Gurgaon, Haryana, India |
SEAG Ventures | Nashville, Tennessee, United States |
Shougang Group Co, Ltd. | Beijing, Beijing, China |
Treasure Factory | Japan, Tokyo |
Ulitzka Venture Capital GmbH | Cologne, Germany, Nordrhein-Westfalen |
Welsh, Carson, Anderson & Stowe | - |
West Coast Investors | California, Santa Monica, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.